The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.

被引:0
|
作者
Banach, M. [1 ]
Jaiswal, V [2 ]
Ang, S. P. [3 ]
Sawhney, A. [4 ]
Deb, N. [5 ]
Penson, P. [6 ]
Toth, P. [7 ]
机构
[1] Med Univ Lodz, Dept Prevent Cardiol & Lipidol, Lodz, Poland
[2] Larkin Community Hosp, Miami, FL USA
[3] Rutgers Hlth, Internal Med, Community Med Ctr, Newark, NJ USA
[4] Crozer Chester Med Ctr, Dept Internal Med, Upland, PA USA
[5] North Bengal Med Coll, Siliguri, India
[6] Liverpool John Moores Univ, Fac Hlth & Appl Social Sci, Liverpool, England
[7] Johns Hopkins Univ, Sch Med, Dept Cardiol, Baltimore, MD USA
关键词
D O I
10.1093/eurheartj/ehae666.2873
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
    Simpson, Ross J., Jr.
    Signorovitch, James
    Birnbaum, Howard
    Ivanova, Jasmina
    Connolly, Cristina
    Kidolezi, Yohanne
    Kuznik, Andreas
    MAYO CLINIC PROCEEDINGS, 2009, 84 (12) : 1065 - 1072
  • [12] Comparison of Efficacy and Safety of Statin–Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies
    Kwang-Hee Shin
    Hye Duck Choi
    American Journal of Cardiovascular Drugs, 2022, 22 : 395 - 406
  • [13] Efficacy of lipid lowering therapy beyond statins to prevent cardiovascular events: A meta-analysis
    Dykun, I.
    Mincu, R.
    Totzeck, M.
    Rassaf, T.
    Mahabadi, A. A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3075 - 3075
  • [14] Non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
    Lobo, L. M.
    Molinero, G.
    Masson, W.
    Siniawski, D.
    Masson, G.
    Huerin, M.
    Nogueira, J. P.
    Benincasa, F.
    Losada, P.
    Suarez, F.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2981 - 2981
  • [15] Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta-Analysis
    Zhang, Xin-Lin
    Lan, Rong-Fang
    Zhang, Xiao-Wen
    Xu, Wei
    Wang, Lian
    Kang, Li-Na
    Xu, Biao
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (16):
  • [16] Effect of Combination Therapy with Ezetimibe and Statins versus Statin Monotherapy on Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kwon, Ryuk Jun
    Cho, Young Hye
    Park, Eun Ju
    Lee, Youngin
    Lee, Sae Rom
    Choi, Jung In
    Lee, Sang Yeoup
    Son, Soo Min
    MEDICINA-LITHUANIA, 2023, 59 (11):
  • [18] Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia
    Chuengsamarn, Somlak
    Rattanamongkoulgul, Suthee
    Suwanwalaikorn, Somponge
    Wattanasirichaigoon, Somkiat
    Kaufman, Larry
    BONE, 2010, 46 (04) : 1011 - 1015
  • [19] Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis
    Hameed, Ishaque
    Shah, Syeda Ayesha
    Aijaz, Ashnah
    Mushahid, Hasan
    Farhan, Syed Husain
    Dada, Muhammad
    Khan, Adam Bilal
    Amjad, Reeha
    Alvi, Fawad
    Murtaza, Mustafa
    Zuberi, Zaid
    Hamza, Mohammad
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (03) : 419 - 431
  • [20] Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
    Masson, Walter
    Lobo, Martin
    Siniawski, Daniel
    Molinero, Graciela
    Masson, Gerardo
    Huerin, Melina
    Nogueira, Juan Patricio
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)